Aliqopa Approved for Follicular Lymphoma

THURSDAY, Sept. 14, 2017 — Aliqopa (copanlisib) has been approved by the U.S. Food and Drug Administration to treat adults with relapsed follicular lymphoma who have received at least two prior treatments with certain other drugs.
Follicular…
Source: Topamax